Surgical management of cervical lymph nodes in differentiated thyroid cancer

Otolaryngologic Clinics of North America

Volumn 43, Issue 2, 2010, Pages 285-300

  Fritze, Danielle ^a   Doherty, Gerard M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cervical lymph nodes; Differentiated thyroid cancer; Dissection; Nodal metastases; Prognosis

Indexed keywords

ASPIRATION BIOPSY; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CERVICAL LYMPH NODE; DISEASE FREE SURVIVAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORTALITY; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; WELL DIFFERENTIATED THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SEER PROGRAM; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 77953254961     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2010.01.005     Document Type: Review

References (62)

1. Society A.C. Cancer facts and figures 2009 2009, American Cancer Society, Atlanta (GA).
2. Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998, 83(12):2638-2648. [comments].
3. Zaydfudim V., Feurer I.D., Griffin M.R., et al. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008, 144(6):1070-1077. [discussion: 1077-8].
4. Ahuja S., Ernst H., Lenz K. Papillary thyroid carcinoma: occurrence and types of lymph node metastases. J Endocrinol Invest 1991, 14(7):543-549.
5. Bardet S., Malville E., Rame J.P., et al. Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 2008, 158(4):551-560.
6. Davidson H.C., Park B.J., Johnson J.T. Papillary thyroid cancer: controversies in the management of neck metastasis. Laryngoscope 2008, 118(12):2161-2165.
7. Kupferman M.E., Patterson M., Mandel S.J., et al. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130(7):857-860.
8. Mirallie E., Visset J., Sagan C., et al. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999, 23(9):970-973. [discussion: 973-4].
9. Qubain S.W., Nakano S., Baba M., et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002, 131(3):249-256.
10. Reddy R.M., Grigsby P.W., Moley J.F., et al. Lymph node metastases in differentiated thyroid cancer under 2 cm. Surgery 2006, 140(6):1050-1054. [discussion: 1054-5].
11. Roh J.L., Kim J.M., Park C.I. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 2008, 15(9):2482-2486.
12. Sato N., Oyamatsu M., Koyama Y., et al. Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland?. J Surg Oncol 1998, 69(3):151-155.
13. Hamoir M., Desuter G., Gregoire V., et al. A proposal for redefining the boundaries of level V in the neck: is dissection of the apex of level V necessary in mucosal squamous cell carcinoma of the head and neck?. Arch Otolaryngol Head Neck Surg 2002, 128(12):1381-1383.
14. Robbins K.T., Clayman G., Levine P.A., et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002, 128(7):751-758.
15. Machens A., Dralle H. Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol 2009, 16(1):171-176.
16. Roh J.L., Kim J.M., Park C.I. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann Surg Oncol 2008, 15(4):1177-1182.
17. Pingpank J.F., Sasson A.R., Hanton A.L., et al. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence. Arch Otolaryngol Head Neck Surg 2002, 128(11):1275-1278.
18. Yanir Y., Doweck I. Regional metastases in well-differentiated thyroid cancer: pattern of spread. Laryngoscope 2008, 118:433-436.
19. Machens A., Holzhausen H.J., Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004, 139(1):43-45.
20. Wang T.S., Dubner S., Sznyter L.A., et al. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg 2004, 130(1):110-113.
21. Scheumann G.F., Gimm O., Wegener G., et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994, 18(4):559-567. [discussion: 567-8].
22. Ito Y., Higashiyama T., Takamura Y., et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 2007, 31(11):2085-2091.
23. Alzahrani A.S., Al Mandil M., Chaudhary M.A., et al. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer. Surgery 2002, 131(4):443-449.
24. McHenry C.R., Rosen I.B., Walfish P.G. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991, 162(4):353-356.
25. Ali S., Tiwari R.M., Snow G.B. False-positive and false-negative neck nodes. Head Neck Surg 1985, 8(2):78-82.
26. Kouvaraki M.A., Shapiro S.E., Fornage B.D., et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003, 134(6):946-954. [discussion: 954-5].
27. Gonzalez H.E., Cruz F., O'Brien A., et al. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2007, 133(12):1258-1262.
28. Ito Y., Tomoda C., Uruno T., et al. Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 2005, 29(7):917-920.
29. Park J.S., Son K.R., Na D.G., et al. Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system. AJR Am J Roentgenol 2009, 192(1):66-72.
30. Shimamoto K., Satake H., Sawaki A., et al. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998, 29(1):4-10.
31. Stulak J.M., Grant C.S., Farley D.R., et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006, 141(5):489-494. [discussion: 494-6].
32. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006, 16(2):109-142.
33. Loh K.C., Greenspan F.S., Gee L., et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997, 82(11):3553-3562.
34. Salvesen H., Njolstad P.R., Akslen L.A., et al. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 1992, 158(11-12):583-589.
35. Wada N., Masudo K., Nakayama H., et al. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. Eur J Surg Oncol 2008, 34(2):202-207.
36. Witte J., Goretzki P.E., Dieken J., et al. Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002, 26(8):1017-1022.
37. Hughes C.J., Shaha A.R., Shah J.P., et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996, 18(2):127-132.
38. Steinmuller T., Klupp J., Rayes N., et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000, 166(1):29-33.
39. Lundgren C.I., Hall P., Dickman P.W., et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006, 106(3):524-531.
40. Podnos Y.D., Smith D., Wagman L.D., et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 2005, 71(9):731-734.
41. Ito Y., Jikuzono T., Higashiyama T., et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2006, 30(1):91-99.
42. Hay I.D., Grant C.S., Taylor W.F., et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987, 102(6):1088-1095.
43. Tisell L.E., Nilsson D., Molne J., et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996, 20(7):854-859.
44. Sywak M., Cornford L., Roach P., et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006, 140(6):1000-1005. [discussion: 1005-7].
45. Simon D., Goretzki P.E., Witte J., et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996, 20(7):860-866. [discussion: 866].
46. Pereira J.A., Jimeno J., Miquel J., et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005, 138(6):1095-1100. [discussion: 1100-1].
47. Salvesen H., Njolstad P.R., Akslen L.A., et al. Thyroid carcinoma: results from surgical treatment in 211 consecutive patients. Eur J Surg 1991, 157(9):521-526.
48. Cross S., Wei J.P., Kim S., et al. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer. J Surg Oncol 2006, 94(8):678-682.
49. Eichhorn W., Tabler H., Lippold R., et al. Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 2003, 13(10):949-958.
50. White M.L., Gauger P.G., Doherty G.M. Central lymph node dissection in differentiated thyroid cancer. World J Surg 2007, 31(5):895-904.
51. Bliss R.D., Gauger P.G., Delbridge L.W. Surgeon's approach to the thyroid gland: surgical anatomy and the importance of technique. World J Surg 2000, 24(8):891-897.
52. Palestini N., Borasi A., Cestino L., et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg 2008, 393(5):693-698.
53. Kim M.K., Mandel S.H., Baloch Z., et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 2004, 130(10):1214-1216.
54. Monchik J.M., DeLellis R.A. Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin. J Surg Oncol 2006, 94(8):714-718.
55. American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009, 19(11):1153-1158.
56. Grodski S., Cornford L., Sywak M., et al. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 2007, 77(4):203-208.
57. Gimm O., Rath F.W., Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998, 85(2):252-254.
58. Noguchi S., Murakami N., Yamashita H., et al. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 1998, 133(3):276-280.
59. Goropoulos A., Karamoshos K., Christodoulou A., et al. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. World J Surg 2004, 28(12):1275-1281.
60. American Thyroid Association Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper D.S., Doherty G.M., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214. [comment].
61. Witt R.L., McNamara A.M. Prognostic factors in mortality and morbidity in patients with differentiated thyroid cancer. Ear Nose Throat J 2002, 81(12):856-863.
62. Cheah W.K., Arici C., Ituarte P.H., et al. Complications of neck dissection for thyroid cancer. World J Surg 2002, 26(8):1013-1016.